Evidence map›Paper›PMID 34798321›Full record

ArticleInfection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases2021

SARS-CoV-2 introduction and lineage dynamics across three epidemic peaks in Southern Brazil: massive spread of P.1.

Ana Paula Muterle Varela, Janira Prichula, Fabiana Quoos Mayer, Richard Steiner Salvato, Fernando Hayashi Sant'Anna, Tatiana Schäffer Gregianini, Letícia Garay Martins, Adriana Seixas, Ana Beatriz Gorini da Veiga

Abstract read
In one paragraph

Article in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Reconstruction of the origin of the first major SARS-CoV-2 outbreak in Germany.Computational and structural biotechnology journal · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ana Paula Muterle VarelaUniversidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Rua Sarmento Leite, 245, 90050-170 Porto Alegre, Rio Grande do Sul, Brazil.
Janira PrichulaUniversidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Rua Sarmento Leite, 245, 90050-170 Porto Alegre, Rio Grande do Sul, Brazil.
Fabiana Quoos MayerCentro de Pesquisa Em Saúde Animal, Instituto de Pesquisas Veterinárias Desidério Finamor, Departamento de Diagnóstico e Pesquisa Agropecuária, Secretaria da Agricultura, Pecuária e Desenvolvimento Rural, Estrada Do Conde, 6000, Sans Souci, 92990-000 Eldorado do Sul, Rio Grande do Sul, Brazil.
Richard Steiner SalvatoLaboratório Central de Saúde Pública, Centro Estadual de Vigilância em Saúde da Secretaria de Saúde do Estado do Rio Grande do Sul (LACEN/CEVS/SES-RS). Av. Ipiranga, 5400, 90610-000 Porto Alegre, Rio Grande do Sul, Brazil.
Fernando Hayashi Sant'AnnaHospital Moinhos de Vento, PROADI - SUS, Rua Ramiro Barcelos, 910 - Moinhos de Vento, Porto Alegre, Rio Grande do Sul, Brazil.
Tatiana Schäffer GregianiniLaboratório Central de Saúde Pública, Centro Estadual de Vigilância em Saúde da Secretaria de Saúde do Estado do Rio Grande do Sul (LACEN/CEVS/SES-RS). Av. Ipiranga, 5400, 90610-000 Porto Alegre, Rio Grande do Sul, Brazil.
Letícia Garay MartinsCentro Estadual de Vigilância em Saúde da Secretaria de Saúde do Estado do Rio Grande do Sul - CEVS/SES-RS. Av. Ipiranga, 5400, 90610-000 Porto Alegre, Rio Grande do Sul, Brazil.
Adriana SeixasUniversidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Rua Sarmento Leite, 245, 90050-170 Porto Alegre, Rio Grande do Sul, Brazil.
Ana Beatriz Gorini da VeigaUniversidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Rua Sarmento Leite, 245, 90050-170 Porto Alegre, Rio Grande do Sul, Brazil. Electronic address: anabgv@ufcspa.edu.br.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genomic surveillance of SARS-CoV-2 is paramount for understanding viral dynamics, contributing to disease control. This study analyzed SARS-CoV-2 genomic diversity in Rio Grande do Sul (RS), Brazil, including the first reported case in each Regional Health Coordination and cases from three epidemic peaks. Ninety SARS-CoV-2 genomes from RS were sequenced and analyzed through comparison with SARS-CoV-2 datasets available in GISAID for phylogenetic inference and mutation analysis. Among the first reported cases, we found the following lineages: B.1 (33.3%), B.1.1.28 (26.7%), B.1.1 (13.3%), B.1.1.33 (10.0%), and A (6.7%), evidencing SARS-CoV-2 introduction by both international origin and community-driven transmission. We found predominance of B.1.1.33 (50.0%) and B.1.1.28 (35.0%) during the first epidemic peak (July-August 2020), emergence of P.2 (55.6%) in the second peak (November-December 2020), and massive spread of P.1 and related sequences (78.4%), such as P.1-like-II, P.1.1 and P.1.2 in the third peak (February-April, 2021). Eighteen novel mutation combinations were found among P.1 genomes, and 22 different spike mutations and/or deletions among P.1 and related sequences. This study shows the dispersion of SARS-CoV-2 lineages in Southern Brazil and describes SARS-CoV-2 diversity during three epidemic peaks, highlighting the spread of P.1 and the high genetic diversity of currently circulating lineages. Genomic monitoring of SARS-CoV-2 is essential to guide health authorities' decisions to control COVID-19 in Brazil.

Indexed as

PhylogenyAdolescentAdultAgedAged, 80 and overBrazilChildChild, PreschoolCitiesCOVID-19FemaleGenome, ViralHumansInfantMaleMiddle AgedSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Viral ProteinsBrazilEpidemic peaksGenomic diversityP.1 lineageSevere acute respiratory syndrome coronavirus 2

Identifiers

PMID34798321
PMCPMC8595253

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.